Bison Wealth’s Horizon Therapeutics HZNP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
– Sell
-10,000
Closed -$196K – 238
2018
Q3
$196K Sell
10,000
-16,179
-62% -$308K 0.13% 212
2018
Q2
$434K Sell
26,179
-1,450
-5% -$22.1K 0.32% 94
2018
Q1
$392K Buy
27,629
+1,140
+4% +$16.8K 0.3% 103
2017
Q4
$387K Sell
26,489
-2,618
-9% -$36.8K 0.28% 96
2017
Q3
$369K Sell
29,107
-551
-2% -$7.01K 0.3% 96
2017
Q2
$352K Sell
29,658
-116
-0.4% -$1.44K 0.29% 96
2017
Q1
$440K Buy
29,774
+2,466
+9% +$39.9K 0.38% 74
2016
Q4
$442K Sell
27,308
-2,237
-8% -$40.6K 0.38% 70
2016
Q3
$536K Sell
29,545
-3,803
-11% -$74.3K 0.45% 69
2016
Q2
$549K Buy
33,348
+5,906
+22% +$95.6K 0.33% 93
2016
Q1
$455K Sell
27,442
-4,276
-13% -$74.8K 0.29% 105
2015
Q4
$687K Buy
31,718
+310
+1% +$6.03K 0.39% 82
2015
Q3
$623K Buy
+31,408
New +$992K 0.41% 78

Other funds holding HZNP

Bison Wealth's HZNP Position: Q4 2018 in Review

Bison Wealth sold out of Horizon Therapeutics (HZNP) in Q4 2018, closing a stake of 10,000 shares — an estimated $196K sold.

Bison Wealth first reported a position in HZNP in Q3 2015 and held it in 13 quarters. The position peaked at $687K in Q4 2015. 239 funds tracked by Wall St. Rank hold HZNP as of Q4 2018.

  • Bison Wealth reported no remaining Horizon Therapeutics position as of Q4 2018 after selling out during the quarter.
  • Bison Wealth sold 10,000 Horizon Therapeutics shares in Q4 2018, an estimated $196K.
  • Bison Wealth first reported a position in Horizon Therapeutics in Q3 2015 and held it in 13 quarters.
  • Bison Wealth's Horizon Therapeutics position peaked at $687K in Q4 2015.
  • 239 funds tracked by Wall St. Rank held Horizon Therapeutics as of Q4 2018.

Based on Bison Wealth's 13F filing for Q4 2018, filed 8 Feb 2019.